Live feed08:28:17·12dANALYSTRatingvia QuantisnowLeerink Partners initiated coverage on Sensei Biotherapeutics with a new price targetByQuantisnow·Wall Street's wire, on your screen.SNSE· Sensei Biotherapeutics Inc.Health CareOriginal source